Absence of activating mutations of the genes encoding the α-subunits of G11 and G(q) in thyroid neoplasia

Journal of Clinical Endocrinology and Metabolism

Volumn 83, Issue 2, 1998, Pages 554-559

  Ringel, Matthew D ^a   Saji, Motoyasu ^a   Schwindinger, William F ^a   Segev, Dorry ^a   Zeiger, Martha A ^a   Levine, Michael A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; AMINO ACID; DNA; GUANINE NUCLEOTIDE BINDING PROTEIN; PHOSPHOLIPASE C; THYROTROPIN RECEPTOR;

ALPHA CHAIN; ARTICLE; CONTROLLED STUDY; DENATURING GRADIENT GEL ELECTROPHORESIS; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; THYROID TUMOR;

ADENOCARCINOMA, FOLLICULAR; ADENOMA; ADENYLATE CYCLASE; BASE SEQUENCE; CARCINOMA, PAPILLARY; DNA; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME ACTIVATION; GTP-BINDING PROTEINS; HUMANS; MUTATION; PHOSPHOLIPASE C; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; THYROID NEOPLASMS;

EID: 0031764971     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.83.2.554     Document Type: Article

References (48)

1. Laugwitz K-L, Allgeier A, Offermans S, et al. 1995 The human thyrotropin receptor: a heptahelical receptor capable of stimulating members of all four G protein families. Proc Natl Acad Sci USA. 93:116-120.
2. q/11. J Biol Chem. 269:13733-13735.
3. Vassart G, Dumont JE. 1992 The thyrotropin receptor and the regulation of thyrocyte function and growth. Endocr Rev. 13:596-611.
4. sα Biochem Biophys Res Commun. 168:1184-1193.
5. s and adenylate cyclase activity in human GH-secreting pituitary adenomas. Nature. 330:566-568.
6. Parma J, Duprez L, Van Sande J, et al. 1993 Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature. 365:649-651.
7. Russo D, Arturi F, Suarez HG, et al. 1996 Thyrotropin receptor gene alterations in thyroid hyperfunctioning adenomas. J Clin Endocrinol Metab. 81:1548-1551.
8. Lyons J, Landis CA, Harsh G, et al. 1990 Two C protein oncogenes in human endocrine tumors. Science. 249:655-659.
9. O'Sullivan C, Barton CM, Staddon SL, Brown CL, Lemoine NR. 1991 Activating point mutations in the gsp oncogene in human thyroid adenomas. Mol Carcinog. 4:345-349.
10. Suarez HG, du Villard JA, Caillou B, Schlumberger M, Parmentier C, Monier R. 1991 gsp mutations in human thyroid tumors. Oncogene. 6:677-679.
11. s in human thyroid neoplasms. J Clin Endocrinol Metab. 76:1446-1451.
12. Goretzki PE, Lyons J, Stacy-Phipps S, et al. 1992 Mutational activation of ras and gsp oncogenes in differentiated thyroid cancer and their biological implications. World J Surg. 16:576-582.
13. Esapa C, Foster S, Johnson S, Jameson JL, Kendall-Taylor P, Harris PE. 1997 G protein and thyrotropin receptor mutations in thyroid neoplasia. J Clin Endocrinol Metab. 82:493-496.
14. Spambalg D, Sharifi N, Elisei R, Gross JL, Medeiros-Neto G, Fagin JA. 1996 Structural studies of the thyrotropin receptor and Gs α in human thyroid cancers: low prevalence of mutations predicts infrequent involvement in malignant transformation. J din Endocrinol Metab. 81:3898-3901.
15. Russo D, Arturi F, Schlumberger M, et al. 1995 Activating mutations of the TSH receptor in differentiated thyroid carcinomas. Oncogene. 11:1907-1911.
16. Ohno M, Endo T, Ohta K, Gunji K, Onaya T. 1995 Point mutations in the thyrotropin receptor in human thyroid tumors. Thyroid. 5:97-100.
17. Russo D, Tumino S, Arturi F, et al. 1997 Detection of an activating mutation of the thyrotropin receptor in a case of an autonomously hyperfunctioning thyroid insular carcinoma. J Clin Endocrinol Metab. 82:735-738.
18. Duprez L, Parma J, Van Sande J, et al. 1993 Germline mutations in the thyrotropin receptor gene cause non-autoimmune autosomal dominant hyperthyroidism. Nat Genet. 7:396-401.
19. Kopp P, Van Sande J, Parma J, et al. 1995 Congenital hyperthyroidism caused by a mutation in the thyrotropin-receptor gene. N Engl J Med. 332:150-154.
20. Michiels F, Caillou B, Talbot M, et al. 1994 Oncogenic potential of guanine nucleotide stimulatory factor α-subunit in thyroid glands of transgenic mice. Proc Natl Acad Sci USA. 91:10488-10492.
21. Ledent C, Dumont JE, Vassart G, Parmentier M. 1992 Thyroid expression of an A2 adenosine receptor induces thyroid hyperplasia and hyperthyroidism. EMBO J. 11:537-542.
22. Zeiger MA, Saji M, Gesev Y, et al. 1997 Thyroid-specific expression of cholera toxin A1 subunit causes thyroid hyperplasia and hyperthyroidism in transgenic mice. Endocrinology. 138:3133-3140.
23. Hamacher C, Studer H, Zbaeren J, Schatz H, Derwahl M. 1995 Expression of functional stimulatory guanine nucleotide binding protein in nonfunctioning thyroid adenomas is not correlated to adenylate cyclase activity and growth of these tumors. J Clin Endocrinol Metab. 80:1724-1732.
24. Taylor SJ, Chae HZ, Rhee SG, Exton JH. 1991 Activation of the beta 1 isozyme of phospholipase C by alpha-subunits of the Gq class of G protein. Nature. 350:516-518.
25. Bacharach LK, Eggo MC, Mak WW, Burrow GN. 1985 Thorbol esters stimulate growth and inhibit differentiation in cultured thyroid cells. Endocrinology. 116:1603-1609.
26. Kobayashi K, Shaver J, Liang W, Siperstein A, Duh Q-Y, Clark O. 1993 Increased phospholipase C activity in neoplastic thyroid membrane. Thyroid. 3:25-29.
27. Hoelting T, Tezelman S, Siperstein AE, Duh Q-Y, Clark O. 1993 Thyrotropin stimulates invasion and growth of follicular thyroid cancer cells via PKC-rather than PKC-activation. Biochem Biophys Res Commun. 195:1230-1236.
28. qα Q209L causes thyroid hyperplasia in transgenic mice. Thyroid. [Suppl 1]6:S-65.
29. 1B-adrenergic receptor transgene promotes malignant transformation of thyroid follicular cells. Endocrinology. 138:369:378.
30. Eastor B, Van Herle AJ, Juillard GJF, et al. 1989 Characterization of a human follicular thyroid carcinoma cell line (UCLA RO82 W-1). Virchows Arch B Cell Pathol. 57:167-174.
31. Dong Q, Shenker A, Way J, et al. 1995 Molecular cloning of human Gαq cDNA and chromosomal localization or the Gαq gene (GNAQ) and a processed pseudogene. Genomics. 30:470-475.
32. Jiang M, Pandey S, Tran VT, Fong HK. 1991 Guanine nucleotide-binding regulatory proteins in retinal pigment epithelial cells. Proc Natl Acad Sci USA. 88:3907-3911.
33. Abrams ES, Murdaugh SE, Lerman LS. 1990 Comprehensive detection of single base changes in human genomic DNA using denaturing gradient gel electrophoresis and a GC clamp. Genomics. 7:463-475.
34. Miric A, Vechia JD, Levine MA. 1493 Heterogeneous mutations in the gene encoding the α-subunit of the stimulatory G protein of adenylyl cyclase in Albright hereditary osteodystrophy. J Clin Endocrinol Metab. 17:1560-1568.
35. Wilson K. 1995 Preparation of genomic DNA from bacteria. In: Current protocols in molecular biology. Ausubel FM, Brent R, Kingston RE, et al., eds. Wiley; 2.41-2.45.
36. Devivo M, Chen J, Codina J, Iyengar R. 1992 Enhanced phospholipase C stimulation and transformation in NIH3T3 cells expressing Q209L Gq-α-subunits. J Biol Chem. 269:17417-17423.
37. Kalinec G, Nagaradi AJ, Hermouet S, Xu N, Gutkind JS. 1992 Mutated α-subunit of the Gq protein induces malignant transformation in NIH3T3 cells. Mol Cell Biol. 12:46887-46893.
38. Van Biesen T, Luttrell LM, Hawes BE, Lefkowitz RJ. 1996 Mitogenic signaling through G protein-coupled receptors. Endocr Rev. 17:698-714.
39. Dong Q, Brucker-Davis F, Weintraub BD, et al. 1996 Screening of candidate oncogenes in human thyrotroph tumors: absence of activating mutations of the Gαq, Gα11, Gαs, or thyrotropin-releasing hormone receptor genes. J Clin Endocrinol Metab. 81:1134-1140.
40. Schwindinger WF, Francomano CA, Levine MA. 1992 Identification of a mutation in the gene encoding the α-subunit of the stimulatory G protein of adenylyl cyclase in McCune-Albright syndrome. Proc Natl Acad Sci USA. 898:5152-5156.
41. Miric A, Levine MA. 1992 Analysis of the preproPTH gene by denaturing gradient gel electrophoresis in familial isolated hypoparathyroidism. J Clin Endocrinol Metab. 74:509-516.
42. Dhanasekaren N, Heasley LE, Johnson GL. 1995 G protein-coupled receptor systems involved in cell growth and oncogenesis. Endocr Rev. 16:259-270.
43. Williamson EA, Ince PG, Harrison D, Kendall-Taylor P, Harris PE. 1995 G-protein mutations in human pituitary adrenocorticotrophic hormone-secreting adenomas. Eur J Clin Invest. 25:128-131.
44. iα-1 in autonomous adenoma. Proc Natl Acad Sci USA. 90:1609-1613.
45. Studer H, Derwahl M. 1995 Mechanisms of nonneoplastic endocrine hyperplasia-a changing concept: a review focused on the thyroid gland. Endocr Rev. 16:411-426.
46. Kopp P, Aeschimann S, Asmis L, Tobler A, Fey MF, Studer H. 1994 Polyclonal and clonal nodules may coexist within multinodular goiters. J Clin Endocrinol Metab. 79:134-139.
47. 2+ influx and protein kinase C activation in sustained cellular responses. Endocr Rev. 16:649-681.
48. Lopez-Ilasaca M, Crespo P, Pellici PG, Gutkind JS, Wetzker R. 1997 Linkage of G protein-coupled receptors to the MAPK signaling pathway through PI 3-kinase γ. Science. 275:394-397.